![John M. Reher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John M. Reher
Fondateur chez
Brain Trust Accelerator Fund
Profil
John M.
Reher is the founder of Accelerate Brain Cancer Cure, Inc. (founded in 2001) and Brain Trust Accelerator Fund (founded in 2006).
He holds the title of President & Executive Director at Accelerate Brain Cancer Cure, Inc. and Managing Director at Brain Trust Accelerator Fund.
Mr. Reher is also the founder of Medicus Venture Partners.
Mr. Reher's current job(s) include Chairman at NeuroTherapia, Inc. (since 2020), Director at BrainScope Co., Inc., Director at Brain Trust Accelerator Fund II LP, and Director at Chase Therapeutics Corp.Mr. Reher's former job(s) include Director at Satoris, Inc., Director at Chase Pharmaceuticals Corp., Principal at Genentech, Inc. (from 1982 to 1988), Principal at Nektar Therapeutics, Principal at Alere San Diego, Inc., Principal at Tularik, Inc., and Principal at G.D.
Searle & Co., Inc. (from 1974 to 1981).
Mr. Reher's education history includes an undergraduate degree from Benedictine University and a graduate degree from Northwestern University.
Postes actifs de John M. Reher
| Sociétés | Poste | Début |
|---|---|---|
Brain Trust Accelerator Fund
 Brain Trust Accelerator Fund Investment ManagersFinance Brain Trust Accelerator invests in companies located in the United States. The firm targets companies operating in the fields of diagnosis and treatment of brain related diseases. It provides financing for early stage capital requirements. | Fondateur | 01/01/2006 |
BrainScope Co., Inc.
 BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Directeur/Membre du Conseil | - |
Brain Trust Accelerator Fund II LP
 Brain Trust Accelerator Fund II LP Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders | Directeur/Membre du Conseil | - |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Président | 22/09/2020 |
Anciens postes connus de John M. Reher
| Sociétés | Poste | Fin |
|---|---|---|
Accelerate Brain Cancer Cure, Inc.
 Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which focuses on speeding the discovery of a cure for brain cancer | Fondateur | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 31/12/1988 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Corporate Officer/Principal | 01/01/1981 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de John M. Reher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Satoris, Inc.
 Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Develops tests for neurological diseases | Commercial Services |
BrainScope Co., Inc.
BrainScope Co., Inc. Packaged SoftwareTechnology Services Operates as a medical neurotechnology company that develops AI-based, portable EEG platform solutions to objectively assess brain health at the point of care | Technology Services |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Medicus Venture Partners
 Medicus Venture Partners Investment ManagersFinance MVP invests in early stage financings of medical and biotechnology companies based in the western US, particularly in California. | Finance |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
Benedictine University
 Benedictine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which focuses on speeding the discovery of a cure for brain cancer | Commercial Services |
Brain Trust Accelerator Fund
Brain Trust Accelerator Fund Investment ManagersFinance Brain Trust Accelerator invests in companies located in the United States. The firm targets companies operating in the fields of diagnosis and treatment of brain related diseases. It provides financing for early stage capital requirements. | Finance |
Brain Trust Accelerator Fund II LP
Brain Trust Accelerator Fund II LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new therapies for diseases with an underlying component of neuroinflammation | Health Technology |
Chase Therapeutics Corp.
Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in developing medications for treating neurodegenerative disorders | Health Technology |
